Acquisition of the approval for marketing the Novel Coronavirus (SARS-CoV-2) Detection Reagent Kit as an In Vitro Diagnostic Product September 17, 2020September 17, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailAcquisition of the approval for marketing the Novel Coronavirus (SARS-CoV-2) Detection Reagent Kit as an In Vitro Diagnostic Product Related News: BD Expands from Cancer Discovery and Diagnosis into…Roche receives FDA approval for first companion…PerkinElmer Expands Salmonella Testing Portfolio…Bruker Announces Acquisition of Tornado Spectral…MKS Instruments and Atotech Receive Approval from…Microtrac MRB Acquires STABINO Product Line From…
